Dr. Richard Ogden and Dr. Regina Rooney Join Hyde Park Communications as Senior Counselors
WASHINGTON - Richard Ogden, Ph.D., a respected HIV/AIDS specialist, and Regina Rooney, Ph.D., an experienced researcher and scientific manager, have joined Hyde Park Communications as Senior Counselors, where they will provide pharmaceutical and other health care companies and organizations with strategic clinical and scientific communications services in a variety of therapeutic areas.
Drs. Ogden and Rooney, who together founded RORR Inc., a medical, scientific, consulting and education company, add further depth to the health care communications services in which Hyde Park Communications specializes.
"We are very excited to have Dr. Ogden and Dr. Rooney, both respected in their scientific fields, join the Hyde Park Communications team," said Jeffrey M. Sandman, CEO of Hyde Park Communications. "Hyde Park has a proven track record of helping health care clients communicate their core messages and build vital stakeholder relationships in areas such as HIV/AIDS, hepatitis C, oncology and other therapeutic areas. The addition of Drs. Ogden and Rooney will provide our clients with greater health care expertise and value as they seek innovative programs to reach their key stakeholders."
Dr. Ogden previously worked at Pfizer Inc, where he was involved with the company's HIV/AIDS medical education programs in the US. He also worked closely in assisting the efforts of the corporate philanthropy group in their support of the Academic Alliance for AIDS Care and Prevention in Africa. He represented Pfizer on HIV/AIDS issues at the World Economic Forum, the Global Business Council and other organizations.
Prior to joining Pfizer, Dr. Ogden was a founding scientist at Agouron Pharmaceuticals, Inc., where he worked on several oncology and viral drug discovery projects. He was a team member in the project which led to the discovery and development of the HIV protease inhibitor Nelfinavir (Viracept®).
He also serves as a member of the scientific advisory boards of several biotechnology companies, and consults to the International AIDS Society.
Dr. Rooney was previously with Invitrogen where she was an R&D Manager, developing products from inception through manufacturing. As R&D Technical Area Manager of the electrophoresis line of products, she managed research and development of products in one of the company's most lucrative business areas. Among the numerous products launched under her supervision were NuPAGE® Novex® Midi-Gels; XCell4SureLockTM Midi-Cell electrophoresis apparatus; NativePAGETM Novex® Bis-Tris Mini Gel System;the MagicMark® product line and the ZOOM® benchtop proteomics line of products.
Prior to her work at Invitrogen, Dr. Rooney worked for Novex, which was later acquired by Invitrogen, as a senior scientist developing and evaluating new technologies for electrophoresis product development. She joined Novex from Nanogen, an electronic microchip-based technology company where she provided the biological and chemical expertise for assay development for the defense department and the private sector. She has authored several patents from her industrial and academic work. Throughout her industrial career, she was responsible for evaluating technologies for intellectual property acquisition, licensing and product planning.
Hyde Park Communications has provided health care communications to leading companies, foundations, non-profits and financial institutions, including Pfizer Inc, Novartis, Johnson & Johnson, Hoffmann-La Roche, Endo Pharmaceuticals, Bristol Myers-Squibb, Morehouse College, W.K. Kellogg Foundation, the National Academy of Sciences, and the South Carolina Department of Health and Education.